The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Novartis; Roche
CHARLI: A phase Ib/II trial of ipilimumab-nivolumab-denosumab or nivolumab-denosumab in patients with unresectable stage III and IV melanoma.
 
Peter Kar Han Lau
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - MSD
Research Funding - Ambrx (Inst); AstraZeneca (Inst); Beigene (Inst); Gilead Sciences (Inst); MSD (Inst); Pimera (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Roche/Genentech
 
Samuel John Harris
Travel, Accommodations, Expenses - MSD Oncology
 
Melissa A. Eastgate
Honoraria - The Limbic
Travel, Accommodations, Expenses - Novartis
 
Damien Kee
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; MSD; Novartis
 
Andrew Mant
No Relationships to Disclose
 
Louise M. Nott
Honoraria - Amgen (Inst); Merck Serono; Merck Sharp & Dohme
Consulting or Advisory Role - Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Novartis; Novartis; Roche
 
Craig Gedye
Consulting or Advisory Role - BCAL Diagnostics; Bristol-Myers Squibb (Inst); Cadex Genomics; Merck Sharp & Dohme (Inst); Novotech
Speakers' Bureau - Limbic Oncology (Inst)
 
Andrisha Jade Inderjeeth
Honoraria - Pfizer
 
Craig Underhill
Consulting or Advisory Role - AstraZeneca; Bayer; Merck Serono
Speakers' Bureau - AstraZeneca; IQvia
Research Funding - Akeso Biopharma (Inst); Arcus Biosciences (Inst); AtriCure (Inst); BeyondSpring Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Deciphera (Inst); novotech (Inst)
 
Alison Margaret Weppler
Consulting or Advisory Role - Bristol-Myers Squibb; Medison; Novartis; Sanofi
 
Roslyn Wallace
No Relationships to Disclose
 
Belinda Lee
Honoraria - Roche
Travel, Accommodations, Expenses - Ipsen; Roche
 
George Au-Yeung
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
 
Narelle Williams
No Relationships to Disclose
 
Daniel Ariza Ospino
No Relationships to Disclose
 
Louise Gonzales
No Relationships to Disclose
 
Mark J. Shackleton
No Relationships to Disclose
 
Serigne N. Lo
No Relationships to Disclose
 
Grant A. McArthur
Research Funding - Bristol-Myers Squibb Australia; Genentech/Roche (Inst); MSD (Inst); Roche (Inst)
Other Relationship - Bristol-Myers Squibb Australia; Novartis
 
Shahneen Sandhu
Honoraria - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst)
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb/Roche (Inst); Genentech (Inst); Merck Sharp and Dohme (Inst); Novartis (Inst)
Speakers' Bureau - AstraZeneca (Inst); Bristol-Myers Squibb; Merck; Roche/Genentech
Research Funding - Amgen (Inst); AstraZeneca (Inst); Endocyte/Advanced Accelerator Applications (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Senhwa Biosciences (Inst)
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis (Inst)